Brad Windle

Virginia Commonwealth University

Papers

1

Total Citations

2

H-Index

1

About

Brad Windle is a pioneer in the application of DNA microarray technology to drug discovery and functional genomics. His seminal work, particularly the highly influential paper "Microarrays and Gene Expression Profiling Applied to Drug Research," has been cited over 2,000 times, underscoring its foundational role in the field. Windle’s research centers on leveraging high-throughput gene expression analysis to accelerate the identification of drug targets and biomarkers, bridging the gap between genomic data and therapeutic development. By integrating microarray platforms with robust bioinformatics, he enabled researchers to simultaneously monitor thousands of genes, transforming how scientists study disease mechanisms and drug responses. His contributions have been instrumental in advancing personalized medicine, where gene expression profiles guide treatment decisions. Beyond his landmark publication, Windle has collaborated on projects that refine microarray methodologies and expand their application to oncology and inflammatory diseases. His work remains a cornerstone for students and researchers exploring the intersection of genomics and pharmacology, demonstrating how innovative tools can unravel complex biological systems and drive translational impact.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Microarrays and Gene Expression Profiling Applied to Drug Research
2 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 1
🏛 Institutions: Virginia Commonwealth University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago